Nikko Asset Management Americas’s bluebird bio BLUE Stock Holding History

Nikko Asset Management Americas’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-8,195	Closed	-$4.88M	–	175
2020 Q1	$4.88M	Sell	8,195 -11,006	-57%	-$10.7M	0.09%	100
2019 Q4	$21.8M	Buy	19,201 +6,990	+57%	+$7.6M	0.34%	68
2019 Q3	$14.5M	Buy	12,211 +1,883	+18%	+$2.88M	0.26%	76
2019 Q2	$17M	Buy	10,328 +2,816	+37%	+$4.87M	0.33%	68
2019 Q1	$15.3M	Buy	+7,512	New	+$13.2M	0.4%	52
2018 Q4	–	Sell	-23	Closed	-$44K	–	147
2018 Q3	$44K	Buy	+23	New	+$47.5K	﹤0.01%	136

Other funds holding BLUE

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Nikko Asset Management Americas's BLUE Position: Q2 2020 in Review

Nikko Asset Management Americas sold out of bluebird bio (BLUE) in Q2 2020, closing a stake of 8,195 shares — an estimated $4.88M sold.

Nikko Asset Management Americas first reported a position in BLUE in Q3 2018 and held it in 6 quarters. The position peaked at $21.8M in Q4 2019. 278 funds tracked by Wall St. Rank hold BLUE as of Q2 2020.

Nikko Asset Management Americas reported no remaining bluebird bio position as of Q2 2020 after selling out during the quarter.
Nikko Asset Management Americas sold 8,195 bluebird bio shares in Q2 2020, an estimated $4.88M.
Nikko Asset Management Americas first reported a position in bluebird bio in Q3 2018 and held it in 6 quarters.
Nikko Asset Management Americas's bluebird bio position peaked at $21.8M in Q4 2019.
278 funds tracked by Wall St. Rank held bluebird bio as of Q2 2020.

Based on Nikko Asset Management Americas's 13F filing for Q2 2020, filed 7 Aug 2020.